These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10212796)

  • 1. Comparison of different techniques for detection of Gal-GalNAc, an early marker of colonic neoplasia.
    Said IT; Shamsuddin AM; Sherief MA; Taleb SG; Aref WF; Kumar D
    Histol Histopathol; 1999 Apr; 14(2):351-7. PubMed ID: 10212796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gal-GalNAc: a biomarker of colon carcinogenesis.
    Yang GY; Shamsuddin AM
    Histol Histopathol; 1996 Jul; 11(3):801-6. PubMed ID: 8839767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the tumor marker D-galactose-beta-(1-->3)-N-acetyl-D-galactosamine in colonic cancer and precancer.
    Xu H; Sakamoto K; Shamsuddin AM
    Arch Pathol Lab Med; 1992 Nov; 116(11):1234-8. PubMed ID: 1332646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.
    Andrews CW; Jessup JM; Goldman H; Hayes DF; Kufe DW; O'Hara CJ; Steele GD
    Cancer; 1993 Dec; 72(11):3185-90. PubMed ID: 7694786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon.
    Shamsuddin AM; Tyner GT; Yang GY
    Cancer Res; 1995 Jan; 55(1):149-52. PubMed ID: 7805025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin profiles in ulcerative colitis with dysplasia and carcinoma.
    Allen DC; Connolly NS; Biggart JD
    Histopathology; 1988 Oct; 13(4):413-24. PubMed ID: 3220466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of dysplasias in ulcerative colitis by a monoclonal antibody: preliminary report.
    Sheyte J; Rubio CA; Mellstedt H
    In Vivo; 1988; 2(6):403-7. PubMed ID: 2979863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
    Carter JH; Deddens JA; Pullman JL; Colligan BM; Whiteley LO; Carter HW
    Clin Cancer Res; 1997 Sep; 3(9):1479-89. PubMed ID: 9815834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas.
    Abe K; Hakomori S; Ohshiba S
    Cancer Res; 1986 May; 46(5):2639-44. PubMed ID: 3516384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa.
    McKenzie KJ; Purnell DM; Shamsuddin AM
    Hum Pathol; 1987 Dec; 18(12):1282-6. PubMed ID: 3500109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy.
    Vucenik I; Gotovac J; Druzijanic N; Shamsuddin AM
    Anticancer Res; 2001; 21(2B):1247-55. PubMed ID: 11396195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misplaced epithelium in ulcerative colitis and Crohn's disease of the colon and its relationship to malignant mucosal changes.
    Allen DC; Biggart JD
    Histopathology; 1986 Jan; 10(1):37-52. PubMed ID: 3957246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
    Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
    Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.
    Karlén P; Young E; Broström O; Löfberg R; Tribukait B; Ost K; Bodian C; Itzkowitz S
    Gastroenterology; 1998 Dec; 115(6):1395-404. PubMed ID: 9834267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical study of expression of lectin-reactive carbohydrate epitopes and glycoligand-binding sites in normal human appendix vermiformis, colonic mucosa, acute appendicitis and colonic adenoma.
    Brinck U; Bosbach R; Korabiowska M; Schauer A; Gabius HJ
    Histol Histopathol; 1996 Oct; 11(4):919-30. PubMed ID: 8930636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.